个人中心 - 老虎社区

VinkaloZendo

IP属地：未知

帖子 · 12帖子 · 12
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- VinkaloZendoVinkaloZendo
  ·2021-11-18
  Ok
  Crypto mining platform Bitdeer to go public through $4 bln SPAC merger
  Nov 18 (Reuters) - Bitdeer Technologies said on Thursday it plans to go public by merging with blank
  Crypto mining platform Bitdeer to go public through $4 bln SPAC merger
  616 1
  2
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-11-18
  Ok
  非常抱歉，此主贴已删除
  648 1
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-11-05
  Buy!
  Novavax Concludes Filing For WHO's Emergency Use Listing For COVID-19 Vaccine
  
  Novavax Concludes Filing For WHO's Emergency Use Listing For COVID-19 Vaccine
  764 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-19
  $TENCENT(00700)$ great!
  321 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-19
  Great read!
  非常抱歉，此主贴已删除
  1,000 评论
  4
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-16
  Agreed
  3 Long-Term Investments You'll Thank Yourself for Later
  Sometimes the best thing you can do for your portfolio is just leave some of its holdings alone... for years at a time.
  3 Long-Term Investments You'll Thank Yourself for Later
  782 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-15
  More infor needed before making decision
  Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?
  Launched on 05/05/2010, the iShares MSCI USA Equal Weighted ETF (EUSA) is a smart beta exchange trad
  Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?
  576 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-15
  Good infor
  Novavax (NVAX) Gains As Market Dips: What You Should Know
  In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previ
  Novavax (NVAX) Gains As Market Dips: What You Should Know
  465 评论
  点赞
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-08
  Oh
  Is It Too Late to Buy Apple Stock?
  The tech giant has generated explosive gains over the past two decades.
  Is It Too Late to Buy Apple Stock?
  566 评论
  1
  分享
  举报
- VinkaloZendoVinkaloZendo
  ·2021-09-02
  Agreed
  非常抱歉，此主贴已删除
  578 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3584268106923844","uuid":"3584268106923844","gmtCreate":1621174881176,"gmtModify":1630478040905,"name":"VinkaloZendo","pinyin":"vinkalozendo","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":29,"tweetSize":12,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.56%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":878715653,"gmtCreate":1637232628288,"gmtModify":1637232628391,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878715653","repostId":"1143297999","repostType":4,"repost":{"id":"1143297999","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637232370,"share":"https://ttm.financial/m/news/1143297999?lang=&edition=full","pubTime":"2021-11-18 18:46","market":"us","language":"en","title":"Crypto mining platform Bitdeer to go public through $4 bln SPAC merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1143297999","media":"Reuters","summary":"Nov 18 (Reuters) - Bitdeer Technologies said on Thursday it plans to go public by merging with blank","content":"<p>Nov 18 (Reuters) - Bitdeer Technologies said on Thursday it plans to go public by merging with blank-check firm Blue Safari Group Acquisition Corp&nbsp;in a deal valuing the cryptocurrency mining platform at $4 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crypto mining platform Bitdeer to go public through $4 bln SPAC merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrypto mining platform Bitdeer to go public through $4 bln SPAC merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-18 18:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nov 18 (Reuters) - Bitdeer Technologies said on Thursday it plans to go public by merging with blank-check firm Blue Safari Group Acquisition Corp&nbsp;in a deal valuing the cryptocurrency mining platform at $4 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143297999","content_text":"Nov 18 (Reuters) - Bitdeer Technologies said on Thursday it plans to go public by merging with blank-check firm Blue Safari Group Acquisition Corp in a deal valuing the cryptocurrency mining platform at $4 billion.","news_type":1,"symbols_score_info":{"BSGA":0.9}},"isVote":1,"tweetType":1,"viewCount":616,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878715343,"gmtCreate":1637232593992,"gmtModify":1637232594048,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878715343","repostId":"2184486862","repostType":2,"isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842032169,"gmtCreate":1636120029306,"gmtModify":1636120593133,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Buy!&nbsp;","listText":"Buy!&nbsp;","text":"Buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842032169","repostId":"2181743347","repostType":2,"repost":{"id":"2181743347","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1636115667,"share":"https://ttm.financial/m/news/2181743347?lang=&edition=full","pubTime":"2021-11-05 20:34","market":"us","language":"en","title":"Novavax Concludes Filing For WHO's Emergency Use Listing For COVID-19 Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2181743347","media":"Benzinga","summary":"\n","content":"<html><body><ul>\n<li><strong>Novavax Inc</strong> (NASDAQ:NVAX) has completed its rolling submission to the World Health Organization (WHO) for emergency use listing (EUL) of NVX-CoV2373, its COVID-19 vaccine candidate.</li>\n<li>Today's filing by Novavax is in addition to a previous filing to WHO by Novavax and <strong>Serum Institute of India Pvt Ltd</strong> (SII).</li>\n<li>The submission includes data from PREVENT-19 Phase 3 trial of 30,000 participants in the U.S. and Mexico that demonstrated 100% protection against moderate and severe disease and 90.4% efficacy overall. </li>\n<li><strong><em>Related Link:</em></strong><em> </em><em>Why Are Novavax Shares Trading Higher Today?</em></li>\n<li>Novavax executed an advance purchase agreement with the European Commission to supply a minimum of 20 million doses and up to 100 million initial doses, with an option to purchase an additional 100 million doses through 2023.</li>\n<li>The Company achieved a capacity of 100 million doses per month for its COVID-19 vaccine as of the end of Q3.</li>\n<li>It is on track to achieve a capacity of 150 million doses per month by the end of Q4 and expect to have the capacity of over 2 billion annual doses in 2022</li>\n<li>Novavax ended Q3 with $1.9 billion in cash, cash equivalents, and restricted cash.</li>\n<li><strong>Price Action:</strong> NVAX shares dropped 8.97% at $163.32 during the premarket session on the last check Friday.</li>\n</ul>\n</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Concludes Filing For WHO's Emergency Use Listing For COVID-19 Vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Concludes Filing For WHO's Emergency Use Listing For COVID-19 Vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-05 20:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><ul>\n<li><strong>Novavax Inc</strong> (NASDAQ:NVAX) has completed its rolling submission to the World Health Organization (WHO) for emergency use listing (EUL) of NVX-CoV2373, its COVID-19 vaccine candidate.</li>\n<li>Today's filing by Novavax is in addition to a previous filing to WHO by Novavax and <strong>Serum Institute of India Pvt Ltd</strong> (SII).</li>\n<li>The submission includes data from PREVENT-19 Phase 3 trial of 30,000 participants in the U.S. and Mexico that demonstrated 100% protection against moderate and severe disease and 90.4% efficacy overall. </li>\n<li><strong><em>Related Link:</em></strong><em> </em><em>Why Are Novavax Shares Trading Higher Today?</em></li>\n<li>Novavax executed an advance purchase agreement with the European Commission to supply a minimum of 20 million doses and up to 100 million initial doses, with an option to purchase an additional 100 million doses through 2023.</li>\n<li>The Company achieved a capacity of 100 million doses per month for its COVID-19 vaccine as of the end of Q3.</li>\n<li>It is on track to achieve a capacity of 150 million doses per month by the end of Q4 and expect to have the capacity of over 2 billion annual doses in 2022</li>\n<li>Novavax ended Q3 with $1.9 billion in cash, cash equivalents, and restricted cash.</li>\n<li><strong>Price Action:</strong> NVAX shares dropped 8.97% at $163.32 during the premarket session on the last check Friday.</li>\n</ul>\n</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.benzinga.com/general/biotech/21/11/23918923/novavax-concludes-filing-for-whos-emergency-use-listing-for-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181743347","content_text":"Novavax Inc (NASDAQ:NVAX) has completed its rolling submission to the World Health Organization (WHO) for emergency use listing (EUL) of NVX-CoV2373, its COVID-19 vaccine candidate.\nToday's filing by Novavax is in addition to a previous filing to WHO by Novavax and Serum Institute of India Pvt Ltd (SII).\nThe submission includes data from PREVENT-19 Phase 3 trial of 30,000 participants in the U.S. and Mexico that demonstrated 100% protection against moderate and severe disease and 90.4% efficacy overall. \nRelated Link: Why Are Novavax Shares Trading Higher Today?\nNovavax executed an advance purchase agreement with the European Commission to supply a minimum of 20 million doses and up to 100 million initial doses, with an option to purchase an additional 100 million doses through 2023.\nThe Company achieved a capacity of 100 million doses per month for its COVID-19 vaccine as of the end of Q3.\nIt is on track to achieve a capacity of 150 million doses per month by the end of Q4 and expect to have the capacity of over 2 billion annual doses in 2022\nNovavax ended Q3 with $1.9 billion in cash, cash equivalents, and restricted cash.\nPrice Action: NVAX shares dropped 8.97% at $163.32 during the premarket session on the last check Friday.","news_type":1,"symbols_score_info":{"NVAX":1}},"isVote":1,"tweetType":1,"viewCount":764,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":887289804,"gmtCreate":1632044792708,"gmtModify":1632803149316,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00700\">$TENCENT(00700)$</a>&nbsp;great!&nbsp;","listText":"<a href=\"https://laohu8.com/S/00700\">$TENCENT(00700)$</a>&nbsp;great!&nbsp;","text":"$TENCENT(00700)$ great!","images":[{"img":"https://static.tigerbbs.com/75934610bd78ad682b4bfea4d47b2efd","width":"1080","height":"2399"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887289804","isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":887289932,"gmtCreate":1632044741226,"gmtModify":1632803149678,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Great read!&nbsp;","listText":"Great read!&nbsp;","text":"Great read!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887289932","repostId":"1198486138","repostType":4,"isVote":1,"tweetType":1,"viewCount":1000,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885522152,"gmtCreate":1631804508176,"gmtModify":1631890660013,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Agreed&nbsp;","listText":"Agreed&nbsp;","text":"Agreed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885522152","repostId":"2167351025","repostType":2,"repost":{"id":"2167351025","kind":"highlight","pubTimestamp":1631793049,"share":"https://ttm.financial/m/news/2167351025?lang=&edition=full","pubTime":"2021-09-16 19:50","market":"us","language":"en","title":"3 Long-Term Investments You'll Thank Yourself for Later","url":"https://stock-news.laohu8.com/highlight/detail?id=2167351025","media":"Motley Fool","summary":"Sometimes the best thing you can do for your portfolio is just leave some of its holdings alone... for years at a time.","content":"<p>Got patience? Plenty of people like to think they're committed to their holdings for the long haul. When things get dicey, though, a sizable swath of this crowd bails out of these investments.</p>\n<p>That can be a big mistake, of course. Most people struggle to see the market's true short-term highs and lows, meaning they get out (or in) at less than ideal times. Often, the best decision you can make is deciding to do nothing at all, taking your lumps on faith those beaten-down stocks will eventually recover.</p>\n<p>With that as the backdrop, here's a closer look at three long-term investments you can actually commit to for the long term. Each <a href=\"https://laohu8.com/S/AONE.U\">one</a> is built not only to last, but to thrive no matter what the future has in store.</p>\n<h2>1. Alphabet</h2>\n<p>Sure, it's technically a consumer tech name, and technology is generally prone to being made obsolete by, well, newer technologies. If there were ever a tech name shielded from the never-ending cycle of improved tech, though, it's likely Google parent<b> Alphabet</b> (NASDAQ:GOOG) (NASDAQ:GOOGL).</p>\n<p>Think about it. While there was a time when consumers clearly functioned without either one, the internet and smartphones have become de facto centerpieces of our lives. Chances are, we're not going to give them up now. And Alphabet is the powerhouse on both fronts, with Google fielding 92% of the world's web searches (according to numbers from GlobalStats' statcounter) and its Android mobile operating system installed on nearly 73% of the world's mobile devices. In fact, when broadening this look to all consumer tech devices like notebooks and tablets, there are more Android-powered devices than there are machines running <b>Microsoft</b> Windows.</p>\n<p>This reach of course positions Google as a gatekeeper to the world wide web, giving Alphabet a variety of ways to monetize all of its platforms.</p>\n<p>And it's done so quite well. The company's year-over-year revenue comparison has fallen in only two quarters since 2006, and one of those quarters was the second quarter of last year when the COVID-19 pandemic was rapidly spreading. In fact, we've also only seen the company's quarterly top line fall twice on a sequential basis -- from the previous calendar quarter -- for the same time frame, and again, one of those two instances was linked to COVID-19. It's all due to consumers' habitual reliance on Google and/or their Android devices.</p>\n<h2>2. Walt Disney</h2>\n<p>Entertainment giant <b>Walt Disney</b> (NYSE:DIS) is nowhere near as consistent as Alphabet when it comes to driving revenue; the pandemic was downright devastating to the company. Nevertheless, Disney is a long-term winner -- not because it does one thing incredibly well, but because it can do a variety of things incredibly well when one piece of its business is struggling.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F643205%2Folder-investors.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>You likely know all about Disney's theme parks and movies. You've also heard plenty of late about their streaming platform, Disney+. What you may not realize, however, is how minor those ventures are compared to the company's other lower-profile operations.</p>\n<p>Before COVID-19 rattled the world beginning in early 2020, television -- Disney, ESPN, and ABC -- collectively accounted for roughly one-third of Walt Disney's revenue, parks and resorts along with licensed product sales made up another third of its top line, films were 16% of its business mix, and its direct-to-consumer and international arm (think Hulu and ESPN+) contributed 13% of its top line. With the pandemic still crimping some segments of the entertainment industry and after the launch of Disney+, direct-to-consumer alone now makes up nearly one-third of the company's top line, while other divisions now contribute relatively less revenue.</p>\n<p>But that's the point. Walt Disney's always got something to sell to someone; oftentimes it's got several products and services to offer to the same consumers. It may not be completely recession-proof, but it's certainly recession-resistant, and it's also able to capture more than its fair share of growth stemming from a strong economy.</p>\n<h2>3. SPDR S&amp;P 500 ETF Trust</h2>\n<p>Finally, add the <b>SPDR S&amp;P 500 ETF Trust</b> (NYSEMKT:SPY) to your list of long-term investments you'll be glad you tucked away.</p>\n<p>Unlike Walt Disney and Alphabet, owning an index-based fund isn't an attempt to outperform the market. It's just an attempt to match the market's overall performance; in some ways it's also an admission that, given enough time, you probably can't beat the market.</p>\n<p>Statistically speaking though, that's not a bad bet.</p>\n<p>Data from Standard &amp; Poor's tells the story, pointing out that measuring results from the end of the year 2000 and the end of 2020, around 94% of actively managed mutual funds available to U.S. investors didn't perform as well as the <b>S&amp;P 500 Index</b> (SNPINDEX:^GSPC). The results are similarly bad when you look at shorter time frames.</p>\n<p>Why can't many of these professional fund managers do what they're presumably trained and paid to do even when they're giving it a full-time effort? Because timing trade entries and exits is hard to do well. That doesn't prevent these folks from attempting it in their hunt for market-beating results, however.</p>\n<p>It's possible you could have better luck. In fact, the whole purpose of highlighting Alphabet and Walt Disney is that these two names have the potential to outpace the broad market's gains.</p>\n<p>Both of those individual stock picks still require long-term holding periods to make the most of their potential, though. So the best thing to do is likely to just leave them alone as long as you can, and round them out with an index-based ETF you can also truly commit to for the long haul.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Long-Term Investments You'll Thank Yourself for Later</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Long-Term Investments You'll Thank Yourself for Later\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-16 19:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/16/3-long-term-investments-youll-thank-yourself-for-l/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Got patience? Plenty of people like to think they're committed to their holdings for the long haul. When things get dicey, though, a sizable swath of this crowd bails out of these investments.\nThat ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/16/3-long-term-investments-youll-thank-yourself-for-l/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOGL":"谷歌A","SPY":"标普500ETF","DIS":"迪士尼","GOOG":"谷歌"},"source_url":"https://www.fool.com/investing/2021/09/16/3-long-term-investments-youll-thank-yourself-for-l/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167351025","content_text":"Got patience? Plenty of people like to think they're committed to their holdings for the long haul. When things get dicey, though, a sizable swath of this crowd bails out of these investments.\nThat can be a big mistake, of course. Most people struggle to see the market's true short-term highs and lows, meaning they get out (or in) at less than ideal times. Often, the best decision you can make is deciding to do nothing at all, taking your lumps on faith those beaten-down stocks will eventually recover.\nWith that as the backdrop, here's a closer look at three long-term investments you can actually commit to for the long term. Each one is built not only to last, but to thrive no matter what the future has in store.\n1. Alphabet\nSure, it's technically a consumer tech name, and technology is generally prone to being made obsolete by, well, newer technologies. If there were ever a tech name shielded from the never-ending cycle of improved tech, though, it's likely Google parent Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL).\nThink about it. While there was a time when consumers clearly functioned without either one, the internet and smartphones have become de facto centerpieces of our lives. Chances are, we're not going to give them up now. And Alphabet is the powerhouse on both fronts, with Google fielding 92% of the world's web searches (according to numbers from GlobalStats' statcounter) and its Android mobile operating system installed on nearly 73% of the world's mobile devices. In fact, when broadening this look to all consumer tech devices like notebooks and tablets, there are more Android-powered devices than there are machines running Microsoft Windows.\nThis reach of course positions Google as a gatekeeper to the world wide web, giving Alphabet a variety of ways to monetize all of its platforms.\nAnd it's done so quite well. The company's year-over-year revenue comparison has fallen in only two quarters since 2006, and one of those quarters was the second quarter of last year when the COVID-19 pandemic was rapidly spreading. In fact, we've also only seen the company's quarterly top line fall twice on a sequential basis -- from the previous calendar quarter -- for the same time frame, and again, one of those two instances was linked to COVID-19. It's all due to consumers' habitual reliance on Google and/or their Android devices.\n2. Walt Disney\nEntertainment giant Walt Disney (NYSE:DIS) is nowhere near as consistent as Alphabet when it comes to driving revenue; the pandemic was downright devastating to the company. Nevertheless, Disney is a long-term winner -- not because it does one thing incredibly well, but because it can do a variety of things incredibly well when one piece of its business is struggling.\nImage source: Getty Images.\nYou likely know all about Disney's theme parks and movies. You've also heard plenty of late about their streaming platform, Disney+. What you may not realize, however, is how minor those ventures are compared to the company's other lower-profile operations.\nBefore COVID-19 rattled the world beginning in early 2020, television -- Disney, ESPN, and ABC -- collectively accounted for roughly one-third of Walt Disney's revenue, parks and resorts along with licensed product sales made up another third of its top line, films were 16% of its business mix, and its direct-to-consumer and international arm (think Hulu and ESPN+) contributed 13% of its top line. With the pandemic still crimping some segments of the entertainment industry and after the launch of Disney+, direct-to-consumer alone now makes up nearly one-third of the company's top line, while other divisions now contribute relatively less revenue.\nBut that's the point. Walt Disney's always got something to sell to someone; oftentimes it's got several products and services to offer to the same consumers. It may not be completely recession-proof, but it's certainly recession-resistant, and it's also able to capture more than its fair share of growth stemming from a strong economy.\n3. SPDR S&P 500 ETF Trust\nFinally, add the SPDR S&P 500 ETF Trust (NYSEMKT:SPY) to your list of long-term investments you'll be glad you tucked away.\nUnlike Walt Disney and Alphabet, owning an index-based fund isn't an attempt to outperform the market. It's just an attempt to match the market's overall performance; in some ways it's also an admission that, given enough time, you probably can't beat the market.\nStatistically speaking though, that's not a bad bet.\nData from Standard & Poor's tells the story, pointing out that measuring results from the end of the year 2000 and the end of 2020, around 94% of actively managed mutual funds available to U.S. investors didn't perform as well as the S&P 500 Index (SNPINDEX:^GSPC). The results are similarly bad when you look at shorter time frames.\nWhy can't many of these professional fund managers do what they're presumably trained and paid to do even when they're giving it a full-time effort? Because timing trade entries and exits is hard to do well. That doesn't prevent these folks from attempting it in their hunt for market-beating results, however.\nIt's possible you could have better luck. In fact, the whole purpose of highlighting Alphabet and Walt Disney is that these two names have the potential to outpace the broad market's gains.\nBoth of those individual stock picks still require long-term holding periods to make the most of their potential, though. So the best thing to do is likely to just leave them alone as long as you can, and round them out with an index-based ETF you can also truly commit to for the long haul.","news_type":1,"symbols_score_info":{"DIS":0.9,"GOOG":0.9,"GOOGL":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":782,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882897562,"gmtCreate":1631672029956,"gmtModify":1631890660015,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"More infor needed before making decision&nbsp;","listText":"More infor needed before making decision&nbsp;","text":"More infor needed before making decision","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882897562","repostId":"2167555562","repostType":2,"repost":{"id":"2167555562","kind":"news","pubTimestamp":1631614810,"share":"https://ttm.financial/m/news/2167555562?lang=&edition=full","pubTime":"2021-09-14 18:20","market":"us","language":"en","title":"Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2167555562","media":"Zacks","summary":"Launched on 05/05/2010, the iShares MSCI USA Equal Weighted ETF (EUSA) is a smart beta exchange trad","content":"<html><body><p>Launched on 05/05/2010, the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Equal Weighted ETF (EUSA) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Blend category of the market.</p>\n<p><b>What Are Smart Beta ETFs?</b></p>\n<p>The ETF industry has long been dominated by products based on market cap weighted indexes, a strategy created to reflect the market or a particular market segment.</p>\n<p>Investors who believe in market efficiency should consider market cap indexes, as they replicate market returns in a low-cost, convenient, and transparent way.</p>\n<p>On the other hand, some investors who believe that it is possible to beat the market by superior stock selection opt to invest in another class of funds that track non-cap weighted strategies--popularly known as smart beta.</p>\n<p>This kind of index follows this same mindset, as it attempts to pick stocks that have better chances of risk-return performance; non-cap weighted strategies base selection on certain fundamental characteristics, or a mix of such characteristics.</p>\n<p>Even though this space provides many choices to investors--think <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the simplest methodologies like equal-weighting and more complicated ones like fundamental and volatility/momentum based weighting--not all have been able to deliver first-rate results.</p>\n<p><b>Fund Sponsor &amp; Index</b></p>\n<p>The fund is managed by Blackrock, and has been able to amass over $467.26 million, which makes it one of the average sized ETFs in the Style Box - All Cap Blend. Before fees and expenses, this particular fund seeks to match the performance of the MSCI USA Equal Weighted Index.</p>\n<p>The MSCI USA Equal Weighted Index represents the MSCI USA Index, measures the performance of equity securities in the top 85% by market capitalization of equity securities listed on stock exchanges in the United States.</p>\n<p><b>Cost &amp; Other Expenses</b></p>\n<p>Cost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive cousins if all other fundamentals are the same.</p>\n<p>With one of the least expensive products in the space, this ETF has annual operating expenses of 0.09%.</p>\n<p>It's 12-month trailing dividend yield comes in at 1.08%.</p>\n<p><b>Sector Exposure and Top Holdings</b></p>\n<p>Even though ETFs offer diversified exposure that minimizes single stock risk, investors should also look at the actual holdings inside the fund. Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis.</p>\n<p>Representing 20% of the portfolio, the fund has heaviest allocation to the Information Technology sector; Healthcare and Industrials round out the top three.</p>\n<p>Looking at individual holdings, Novavax Inc (NVAX) accounts for about 0.24% of total assets, followed by <a href=\"https://laohu8.com/S/ENPH\">Enphase Energy</a> Inc (ENPH) and Moderna Inc (MRNA).</p>\n<p>The top 10 holdings account for about 2.27% of total assets under management.</p>\n<p><b>Performance and Risk</b></p>\n<p>So far this year, EUSA return is roughly 22.50%, and was up about 43.31% in the last one year (as of 09/14/2021). During this past 52-week period, the fund has traded between $59.14 and $88.24.</p>\n<p>The fund has a beta of 1.13 and standard deviation of 23.87% for the trailing three-year period, which makes EUSA a medium risk choice in this particular space. With about 632 holdings, it effectively diversifies company-specific risk.</p>\n<p><b>Alternatives</b></p>\n<p>IShares MSCI USA Equal Weighted ETF is a reasonable option for investors seeking to outperform the Style Box - All Cap Blend segment of the market. However, there are other ETFs in the space which investors could consider.</p>\n<p>IShares Core S&amp;P Total U.S. Stock Market ETF (ITOT) tracks S&amp;P Total Market Index and the Vanguard Total Stock Market ETF (VTI) tracks CRSP US Total Market Index. IShares Core S&amp;P Total U.S. Stock Market ETF has $42.71 billion in assets, Vanguard Total Stock Market ETF has $264.76 billion. ITOT has an expense ratio of 0.03% and VTI charges 0.03%.</p>\n<p>Investors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Style Box - All Cap Blend.</p>\n<p><b>Bottom Line</b></p>\n<p>To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.</p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\n<a href=\"https://laohu8.com/S/ISQMF\">iShares MSCI</a> USA Equal Weighted ETF (EUSA): ETF Research Reports\n<br/> \n<br/>\n<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (MRNA) : Free Stock Analysis Report\n<br/> \n<br/>\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n<br/> \n<br/>\nEnphase Energy, Inc. (ENPH) : Free Stock Analysis Report\n<br/> \n<br/>\nVanguard Total Stock Market ETF (VTI): ETF Research Reports\n<br/> \n<br/>\n<a href=\"https://laohu8.com/S/EEME\">iShares</a> Core S&amp;P Total U.S. Stock Market ETF (ITOT): ETF Research Reports\n<br/> \n<br/>\nTo read this article on Zacks.com click here.</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-14 18:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ishares-msci-usa-equal-weighted-102010987.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Launched on 05/05/2010, the iShares MSCI USA Equal Weighted ETF (EUSA) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Blend category of the market.\nWhat Are ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ishares-msci-usa-equal-weighted-102010987.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/clODVF3EcX410F.EsuMH4Q--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/CorpxfcSD3xaruoFanouDg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","EUSA":"iShares MSCI USA Index Fund"},"source_url":"https://finance.yahoo.com/news/ishares-msci-usa-equal-weighted-102010987.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2167555562","content_text":"Launched on 05/05/2010, the iShares MSCI USA Equal Weighted ETF (EUSA) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Blend category of the market.\nWhat Are Smart Beta ETFs?\nThe ETF industry has long been dominated by products based on market cap weighted indexes, a strategy created to reflect the market or a particular market segment.\nInvestors who believe in market efficiency should consider market cap indexes, as they replicate market returns in a low-cost, convenient, and transparent way.\nOn the other hand, some investors who believe that it is possible to beat the market by superior stock selection opt to invest in another class of funds that track non-cap weighted strategies--popularly known as smart beta.\nThis kind of index follows this same mindset, as it attempts to pick stocks that have better chances of risk-return performance; non-cap weighted strategies base selection on certain fundamental characteristics, or a mix of such characteristics.\nEven though this space provides many choices to investors--think one of the simplest methodologies like equal-weighting and more complicated ones like fundamental and volatility/momentum based weighting--not all have been able to deliver first-rate results.\nFund Sponsor & Index\nThe fund is managed by Blackrock, and has been able to amass over $467.26 million, which makes it one of the average sized ETFs in the Style Box - All Cap Blend. Before fees and expenses, this particular fund seeks to match the performance of the MSCI USA Equal Weighted Index.\nThe MSCI USA Equal Weighted Index represents the MSCI USA Index, measures the performance of equity securities in the top 85% by market capitalization of equity securities listed on stock exchanges in the United States.\nCost & Other Expenses\nCost is an important factor in selecting the right ETF, and cheaper funds can significantly outperform their more expensive cousins if all other fundamentals are the same.\nWith one of the least expensive products in the space, this ETF has annual operating expenses of 0.09%.\nIt's 12-month trailing dividend yield comes in at 1.08%.\nSector Exposure and Top Holdings\nEven though ETFs offer diversified exposure that minimizes single stock risk, investors should also look at the actual holdings inside the fund. Luckily, most ETFs are very transparent products that disclose their holdings on a daily basis.\nRepresenting 20% of the portfolio, the fund has heaviest allocation to the Information Technology sector; Healthcare and Industrials round out the top three.\nLooking at individual holdings, Novavax Inc (NVAX) accounts for about 0.24% of total assets, followed by Enphase Energy Inc (ENPH) and Moderna Inc (MRNA).\nThe top 10 holdings account for about 2.27% of total assets under management.\nPerformance and Risk\nSo far this year, EUSA return is roughly 22.50%, and was up about 43.31% in the last one year (as of 09/14/2021). During this past 52-week period, the fund has traded between $59.14 and $88.24.\nThe fund has a beta of 1.13 and standard deviation of 23.87% for the trailing three-year period, which makes EUSA a medium risk choice in this particular space. With about 632 holdings, it effectively diversifies company-specific risk.\nAlternatives\nIShares MSCI USA Equal Weighted ETF is a reasonable option for investors seeking to outperform the Style Box - All Cap Blend segment of the market. However, there are other ETFs in the space which investors could consider.\nIShares Core S&P Total U.S. Stock Market ETF (ITOT) tracks S&P Total Market Index and the Vanguard Total Stock Market ETF (VTI) tracks CRSP US Total Market Index. IShares Core S&P Total U.S. Stock Market ETF has $42.71 billion in assets, Vanguard Total Stock Market ETF has $264.76 billion. ITOT has an expense ratio of 0.03% and VTI charges 0.03%.\nInvestors looking for cheaper and lower-risk options should consider traditional market cap weighted ETFs that aim to match the returns of the Style Box - All Cap Blend.\nBottom Line\nTo learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\niShares MSCI USA Equal Weighted ETF (EUSA): ETF Research Reports\n \n\nModerna, Inc. (MRNA) : Free Stock Analysis Report\n \n\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n \n\nEnphase Energy, Inc. (ENPH) : Free Stock Analysis Report\n \n\nVanguard Total Stock Market ETF (VTI): ETF Research Reports\n \n\niShares Core S&P Total U.S. Stock Market ETF (ITOT): ETF Research Reports\n \n\nTo read this article on Zacks.com click here.","news_type":1,"symbols_score_info":{"EUSA":1,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":576,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882897995,"gmtCreate":1631671991517,"gmtModify":1631890660017,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Good infor","listText":"Good infor","text":"Good infor","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882897995","repostId":"2167563598","repostType":2,"repost":{"id":"2167563598","kind":"news","pubTimestamp":1631655909,"share":"https://ttm.financial/m/news/2167563598?lang=&edition=full","pubTime":"2021-09-15 05:45","market":"us","language":"en","title":"Novavax (NVAX) Gains As Market Dips: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2167563598","media":"Zacks","summary":"In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previ","content":"<html><body><p>In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previous day. This change outpaced the S&amp;P 500's 0.58% loss on the day.</p>\n<p>Prior to today's trading, shares of the vaccine maker had gained 1.97% over the past month. This has outpaced the Medical sector's loss of 0.62% and the S&amp;P 500's gain of 0.16% in that time.</p>\n<p>Investors will be hoping for strength from NVAX as it approaches its next earnings release. In that report, analysts expect NVAX to post earnings of -$4.04 per share. This would mark a year-over-year decline of 25.86%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $306.8 million, up 95.39% from the year-ago period.</p>\n<p>Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$8.37 per share and revenue of $1.77 billion. These totals would mark changes of -15.13% and +273.17%, respectively, from last year.</p>\n<p>Investors should also note any recent changes to analyst estimates for NVAX. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.</p>\n<p>Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.</p>\n<p>The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 3.86% lower within the past month. NVAX is currently a Zacks Rank #3 (Hold).</p>\n<p>The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 196, which puts it in the bottom 23% of all 250+ industries.</p>\n<p>The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.</p>\n<p>Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.</p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax (NVAX) Gains As Market Dips: What You Should Know</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax (NVAX) Gains As Market Dips: What You Should Know\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-15 05:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/novavax-nvax-gains-market-dips-214509891.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previous day. This change outpaced the S&P 500's 0.58% loss on the day.\nPrior to today's trading, shares ...</p>\n\n<a href=\"https://finance.yahoo.com/news/novavax-nvax-gains-market-dips-214509891.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/r3XbmSiK8NsZqGuIQaOcPA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://finance.yahoo.com/news/novavax-nvax-gains-market-dips-214509891.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2167563598","content_text":"In the latest trading session, Novavax (NVAX) closed at $234.29, marking a +0.2% move from the previous day. This change outpaced the S&P 500's 0.58% loss on the day.\nPrior to today's trading, shares of the vaccine maker had gained 1.97% over the past month. This has outpaced the Medical sector's loss of 0.62% and the S&P 500's gain of 0.16% in that time.\nInvestors will be hoping for strength from NVAX as it approaches its next earnings release. In that report, analysts expect NVAX to post earnings of -$4.04 per share. This would mark a year-over-year decline of 25.86%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $306.8 million, up 95.39% from the year-ago period.\nLooking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$8.37 per share and revenue of $1.77 billion. These totals would mark changes of -15.13% and +273.17%, respectively, from last year.\nInvestors should also note any recent changes to analyst estimates for NVAX. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.\nBased on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.\nThe Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 3.86% lower within the past month. NVAX is currently a Zacks Rank #3 (Hold).\nThe Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 196, which puts it in the bottom 23% of all 250+ industries.\nThe Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.\nBe sure to follow all of these stock-moving metrics, and many more, on Zacks.com.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nNovavax, Inc. (NVAX) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.","news_type":1,"symbols_score_info":{"NVAX":1}},"isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889933352,"gmtCreate":1631100972376,"gmtModify":1631890660021,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/889933352","repostId":"2165360472","repostType":4,"repost":{"id":"2165360472","kind":"highlight","pubTimestamp":1631100780,"share":"https://ttm.financial/m/news/2165360472?lang=&edition=full","pubTime":"2021-09-08 19:33","market":"us","language":"en","title":"Is It Too Late to Buy Apple Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2165360472","media":"Motley Fool","summary":"The tech giant has generated explosive gains over the past two decades.","content":"<p><b>Apple</b>'s (NASDAQ:AAPL) stock rallied roughly 48,660% over the past 20 years and recently hit a new all-time high. Once dismissed as an also-ran of the tech sector, Apple's introductions of the iPod, iPhone, and iPad under Steve Jobs turned it into <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the world's most valuable tech companies.</p>\n<p>After Jobs passed away in 2011, Apple continued to evolve under Tim Cook with new iPhones, fresh hardware devices like the Apple Watch, and the expansion of its software and services ecosystem. Apple also reinstated its dividend, initiated aggressive buybacks, and invested in next-gen technologies like augmented reality and connected vehicles.</p>\n<p>Apple became a trillion-dollar company in 2018 and a $2 trillion company last year. But after those massive long-term gains, investors who don't already own Apple might be wondering if it's too late to buy the stock. Let's examine the bearish and bullish cases for Apple to decide.</p>\n<p><img src=\"https://static.tigerbbs.com/cc0db7aae99872ee508b75351882fff1\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Apple.</p>\n<p><b>Why it might be too late to buy Apple</b></p>\n<p>The bears often cite Apple's dependence on the iPhone, which generated 54% of its revenue in the first nine months of fiscal 2021, as its main weakness. Apple's iPhone sales rose this year as more users bought its first lineup of 5G iPhones, but that growth will likely decelerate next year as fewer consumers consider the iPhone 13 to be a crucial upgrade. Intense competition and the commoditization of the smartphone market also remain major long-term threats to Apple's biggest business.</p>\n<p>It's unclear if Apple will ever deliver another revolutionary product like the iPhone, and the lack of clarity regarding its future plans is worrisome.</p>\n<p>Another soft spot is Apple's dependence on China, which accounted for 19% of its revenue in the first nine months of the year. China is Apple's fastest-growing market, but it's also a minefield of unpredictable regulations, tariffs, and nationalism-driven boycotts. If the ongoing trade and tech tensions between the U.S. and China escalate, Apple could be an easy target for retaliatory regulations, taxes, or bans.</p>\n<p>The bears will also point out that Apple has grown too dependent on buybacks in recent years. It spent $82.4 billion on buybacks over the past 12 months, and even funded some of those purchases with fresh debt. Apple could arguably have spent more of that cash on investments and acquisitions to diversify its business away from the iPhone.</p>\n<p>Lastly, Apple's expansion of its services ecosystem faces significant long-term challenges. Its App Store faces pressure to lower its fees, while many of its new subscription services (Apple TV+, Apple Music, and Apple Arcade) are likely operating at losses to lock in more users.</p>\n<p><b>Why it might not be too late to buy Apple</b></p>\n<p>The bulls believe Apple's iPhones will continue to lock in consumers with their prisoner-taking software ecosystems, and that the device's sales -- while cyclical -- will remain stable over the long term.</p>\n<p><img src=\"https://static.tigerbbs.com/2f0193c46e290e13c95a5514f952d998\" tg-width=\"700\" tg-height=\"451\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Apple.</p>\n<p>Apple also isn't sitting still as it milks the iPhone dry. It's reportedly developing augmented reality devices, an electric vehicle, and other new services to expand beyond single hardware platforms.</p>\n<p>As for China, the bulls believe Apple will make concessions (likely in terms of censorship and data protection) to remain in the government's good graces, and that its symbiotic relationship with China through<b> Foxconn</b> (OTC:FXCNF) -- the country's largest private employer&nbsp;-- will shield it from retaliatory regulations.</p>\n<p>The bulls will point out that while Apple spends a lot of cash on buybacks, it was still sitting on $193.6 billion in cash, cash equivalents, and marketable securities last quarter -- which gives it plenty of room for future acquisitions. Furthermore, it only issued new debt because interest rates were so low.</p>\n<p>As for the expansion of its ecosystem, Apple can offset the losses at its newer subscription services, which now serve more than 700 million subscribers worldwide, with its higher-margin App Store revenue -- even if certain developers and regulators pressure it to lower its 15%-30% cut. Locking in more subscribers also tethers them more tightly to the iPhone and its other hardware devices.</p>\n<p>Lastly, Apple's stock is still reasonably valued. Analysts expect its revenue and earnings to rise 33% and 70%, respectively, this year, followed by more modest growth next year as it laps the launch of the iPhone 12. The stock trades at 27 times forward earnings and seven times next year's sales.</p>\n<p><b>It's still a great long-term investment</b></p>\n<p>I traded in and out of Apple for years before buying a long-term position in early 2018. If I had simply bought and held Apple instead of trading it before then, I'd be sitting on much bigger gains.</p>\n<p>Therefore, I believe Apple is still a great long-term investment, and it still isn't too late to buy the stock. It probably won't replicate its gains from the past two decades over the next 20 years, but its core businesses remain strong, its brand inspires fierce loyalty, and it has plenty of cash to fund its future expansion plans beyond the iPhone.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Too Late to Buy Apple Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Too Late to Buy Apple Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-08 19:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/08/is-it-too-late-to-buy-apple-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple's (NASDAQ:AAPL) stock rallied roughly 48,660% over the past 20 years and recently hit a new all-time high. Once dismissed as an also-ran of the tech sector, Apple's introductions of the iPod, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/08/is-it-too-late-to-buy-apple-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/09/08/is-it-too-late-to-buy-apple-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165360472","content_text":"Apple's (NASDAQ:AAPL) stock rallied roughly 48,660% over the past 20 years and recently hit a new all-time high. Once dismissed as an also-ran of the tech sector, Apple's introductions of the iPod, iPhone, and iPad under Steve Jobs turned it into one of the world's most valuable tech companies.\nAfter Jobs passed away in 2011, Apple continued to evolve under Tim Cook with new iPhones, fresh hardware devices like the Apple Watch, and the expansion of its software and services ecosystem. Apple also reinstated its dividend, initiated aggressive buybacks, and invested in next-gen technologies like augmented reality and connected vehicles.\nApple became a trillion-dollar company in 2018 and a $2 trillion company last year. But after those massive long-term gains, investors who don't already own Apple might be wondering if it's too late to buy the stock. Let's examine the bearish and bullish cases for Apple to decide.\n\nImage source: Apple.\nWhy it might be too late to buy Apple\nThe bears often cite Apple's dependence on the iPhone, which generated 54% of its revenue in the first nine months of fiscal 2021, as its main weakness. Apple's iPhone sales rose this year as more users bought its first lineup of 5G iPhones, but that growth will likely decelerate next year as fewer consumers consider the iPhone 13 to be a crucial upgrade. Intense competition and the commoditization of the smartphone market also remain major long-term threats to Apple's biggest business.\nIt's unclear if Apple will ever deliver another revolutionary product like the iPhone, and the lack of clarity regarding its future plans is worrisome.\nAnother soft spot is Apple's dependence on China, which accounted for 19% of its revenue in the first nine months of the year. China is Apple's fastest-growing market, but it's also a minefield of unpredictable regulations, tariffs, and nationalism-driven boycotts. If the ongoing trade and tech tensions between the U.S. and China escalate, Apple could be an easy target for retaliatory regulations, taxes, or bans.\nThe bears will also point out that Apple has grown too dependent on buybacks in recent years. It spent $82.4 billion on buybacks over the past 12 months, and even funded some of those purchases with fresh debt. Apple could arguably have spent more of that cash on investments and acquisitions to diversify its business away from the iPhone.\nLastly, Apple's expansion of its services ecosystem faces significant long-term challenges. Its App Store faces pressure to lower its fees, while many of its new subscription services (Apple TV+, Apple Music, and Apple Arcade) are likely operating at losses to lock in more users.\nWhy it might not be too late to buy Apple\nThe bulls believe Apple's iPhones will continue to lock in consumers with their prisoner-taking software ecosystems, and that the device's sales -- while cyclical -- will remain stable over the long term.\n\nImage source: Apple.\nApple also isn't sitting still as it milks the iPhone dry. It's reportedly developing augmented reality devices, an electric vehicle, and other new services to expand beyond single hardware platforms.\nAs for China, the bulls believe Apple will make concessions (likely in terms of censorship and data protection) to remain in the government's good graces, and that its symbiotic relationship with China through Foxconn (OTC:FXCNF) -- the country's largest private employer -- will shield it from retaliatory regulations.\nThe bulls will point out that while Apple spends a lot of cash on buybacks, it was still sitting on $193.6 billion in cash, cash equivalents, and marketable securities last quarter -- which gives it plenty of room for future acquisitions. Furthermore, it only issued new debt because interest rates were so low.\nAs for the expansion of its ecosystem, Apple can offset the losses at its newer subscription services, which now serve more than 700 million subscribers worldwide, with its higher-margin App Store revenue -- even if certain developers and regulators pressure it to lower its 15%-30% cut. Locking in more subscribers also tethers them more tightly to the iPhone and its other hardware devices.\nLastly, Apple's stock is still reasonably valued. Analysts expect its revenue and earnings to rise 33% and 70%, respectively, this year, followed by more modest growth next year as it laps the launch of the iPhone 12. The stock trades at 27 times forward earnings and seven times next year's sales.\nIt's still a great long-term investment\nI traded in and out of Apple for years before buying a long-term position in early 2018. If I had simply bought and held Apple instead of trading it before then, I'd be sitting on much bigger gains.\nTherefore, I believe Apple is still a great long-term investment, and it still isn't too late to buy the stock. It probably won't replicate its gains from the past two decades over the next 20 years, but its core businesses remain strong, its brand inspires fierce loyalty, and it has plenty of cash to fund its future expansion plans beyond the iPhone.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":566,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812648880,"gmtCreate":1630586864540,"gmtModify":1631890660024,"author":{"id":"3584268106923844","authorId":"3584268106923844","name":"VinkaloZendo","avatar":"https://static.tigerbbs.com/8a32aef07a08a12ffb1b8024b3b3abbf","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584268106923844","authorIdStr":"3584268106923844"},"themes":[],"htmlText":"Agreed","listText":"Agreed","text":"Agreed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/812648880","repostId":"1100563900","repostType":2,"isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}